IFNG and Alzheimer disease: In a very recently published study, Baruch and colleagues proposed a novel treatment strategy to target AD via programmed death-1 (PD-1) inhibition and thereby increasing the recruitment of Ly6Chi monocytes to the CNS in an IFN-γ dependent manner [104].